Document is current
Any future updates will be listed below
-
Authors
Ashiri, Alireza
Rafiei, Abdollah
Noordin, Rahmah
Anuar, Nor Suhada
Teimoori, Ali
Ansari-Moghaddam, Bijan
Beiromvand, Molouk
-
Funding
Funding for this research was provided by:
Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (CMRC-0249, CMRC-0249, CMRC-0249, CMRC-0249, CMRC-0249, CMRC-0249, CMRC-0249)
- License Information
-
More Information
Article History
Received: 22 March 2025
Accepted: 20 June 2025
First Online: 22 July 2025
Declarations
:
: The protocol of this study was approved by the Ethics Committee of the Ahvaz Jundishapur University of Medical Sciences, approval no. IR.AJUMS.MEDICINE.REC.1402.087. Participants or their parents (children) were informed about the study’s objectives and provided written consent. Copro-positive cases were referred to an infectious disease specialist for treatment.
: Not applicable.
: R.N. and N.S.A. developed the prototype IgG4 rapid tests, which were shipped from Malaysia to Iran. They had no part in the actual testing of samples, so the potential conflict of interest is minimal. Other authors have no competing interests.
